Global Biologics Consulting Services Market is poised to witness a CAGR of >15%, driven by the growing biopharmaceutical market

June 20, 2022

While small molecules are either made synthetically or purified from plants, biologics are medicines made from living cells. Although small molecules comprise >90% of drugs on the market, pharmaceutical and biotech companies are gradually shifting their focus to manufacturing and developing highly profitable biologics drugs.

Complex Nature of Biologics and its Growing Importance Drives the Demand for Biologics Consulting Services Market

Compared to small molecules, biologics are large, highly complex, heterogeneous molecules, more expensive, sensitive to external conditions, need to go through challenging manufacturing processes and have stringent regulatory requirements, thus requiring a greater level of expertise.

With the increasingly complex and consistently evolving biopharma industry, companies are looking for consultancies that are able to provide significant regulatory leadership, product development consulting, and expertise in all stages from early-stage discovery to commercialization. Moreover, the growing importance of new biologics drugs is seen over the last few years, with biologics contributing to 25% of new molecule approvals in the US in 2020. This further boosts the demand for biologics consulting services market.

Rising Demand for Advanced Technologies Consulting Services

Advanced therapies, such as cell and gene therapies and personalized vaccines require specialized expertise throughout the development, manufacturing, and regulatory process. Latest vaccine technologies like viral vector and mRNA where demand exceeds supply and capabilities/technical expertise may not exist even in large biopharmaceutical companies. Moreover, the rapidly evolving regulatory landscape makes it essential to have up-to-date knowledge and expertise to successfully develop a product and gain a centralized market authorization (MA) in Europe and/or a Biologic License Authorization (BLA) in the United States. With the significantly growing demand for advanced biologics therapies, there is a corresponding demand for biologics consulting services.

North America Leads the Adoption of Biologics Consulting Services Market

From a geographical perspective, North America has a larger market share of the biologics consulting services market. This is mainly attributed to the rapidly growing biopharmaceutical industry, favorable government policies supporting biologics innovation, the presence of biologics consulting firms, significant R&D spending in USA, strict FDA regulations and a greater focus on advanced therapies.

Competitive Landscape Analysis: Biologics Consulting Services Market

The global biologics consulting services market is highly competitive and fragmented. Some of the top and emerging players in this market are IQVIA, NNE, ProductLife Group, Clarkston Consulting, Fingerpaint, Azenta Life Sciences, Biologics Consulting Group, UDG Healthcare, ProPharma Group, APCER Life Sciences, Freyr Solutions, ADVANCED CELL & GENE THERAPY, LLC, Dark Horse Consulting, and eXmoor pharma concepts limited.

As a major growth strategy, all key companies operating in the biologics consulting services market are focusing on adding/expanding their portfolio with high-growing advanced therapy consulting services.

Get Detailed Insights on Biologics Consulting Services Market @